Diaceutics PLC Valuation
| DIUXF Stock | USD 1.37 0.00 0.00% |
Today, the firm appears to be fairly valued. Diaceutics PLC shows a prevailing Real Value of $1.37 per share. The current price of the firm is $1.37. Our model computes the value of Diaceutics PLC from reviewing the firm fundamentals such as Operating Margin of 0 %, current valuation of 54.7 M, and Profit Margin of 0.01 % as well as analyzing its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Diaceutics PLC's price fluctuation is very steady at this time. Calculation of the real value of Diaceutics PLC is based on 3 months time horizon. Increasing Diaceutics PLC's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Diaceutics pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Diaceutics PLC. Since Diaceutics PLC is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Diaceutics Pink Sheet. However, Diaceutics PLC's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.37 | Real 1.37 | Hype 1.37 | Naive 1.37 |
The real value of Diaceutics Pink Sheet, also known as its intrinsic value, is the underlying worth of Diaceutics PLC Company, which is reflected in its stock price. It is based on Diaceutics PLC's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Diaceutics PLC's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Diaceutics PLC helps investors to forecast how Diaceutics pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Diaceutics PLC more accurately as focusing exclusively on Diaceutics PLC's fundamentals will not take into account other important factors: Diaceutics PLC Total Value Analysis
Diaceutics PLC is currently anticipated to have takeover price of 54.7 M with market capitalization of 94.61 M, debt of 1.56 M, and cash on hands of 19.68 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Diaceutics PLC fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
54.7 M | 94.61 M | 1.56 M | 19.68 M |
Diaceutics PLC Investor Information
About 47.0% of the company shares are held by company insiders. The book value of Diaceutics PLC was currently reported as 0.49. The company has Price/Earnings (P/E) ratio of 112.0. Diaceutics PLC had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from Diaceutics PLC's historical financial statements, Diaceutics PLC is not in a good financial situation at this time. It has a very high probability of going through financial hardship in February.Diaceutics PLC Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of Diaceutics implies not a very effective usage of assets in January.Diaceutics PLC Ownership Allocation
Diaceutics PLC holds a total of 84.47 Million outstanding shares. Diaceutics PLC retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Diaceutics PLC Profitability Analysis
The company reported the revenue of 13.94 M. Net Income was 561 K with profit before overhead, payroll, taxes, and interest of 10.73 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Diaceutics PLC's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Diaceutics PLC and how it compares across the competition.
About Diaceutics PLC Valuation
The pink sheet valuation mechanism determines Diaceutics PLC's current worth on a weekly basis. Our valuation model uses a comparative analysis of Diaceutics PLC. We calculate exposure to Diaceutics PLC's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Diaceutics PLC's related companies.Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. Diaceutics PLC was incorporated in 2005 and is headquartered in Belfast, the United Kingdom. Diaceutics Plc is traded on OTC Exchange in the United States.
8 Steps to conduct Diaceutics PLC's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Diaceutics PLC's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Diaceutics PLC's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Diaceutics PLC's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Diaceutics PLC's revenue streams: Identify Diaceutics PLC's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Diaceutics PLC's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Diaceutics PLC's growth potential: Evaluate Diaceutics PLC's management, business model, and growth potential.
- Determine Diaceutics PLC's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Diaceutics PLC's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Diaceutics PLC Growth Indicators
Investing in growth stocks can be very risky. If the company such as Diaceutics PLC does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 84.1 M | |
| Forward Price Earnings | 25.3165 | |
| Retained Earnings | 4.1 M |
Complementary Tools for Diaceutics Pink Sheet analysis
When running Diaceutics PLC's price analysis, check to measure Diaceutics PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Diaceutics PLC is operating at the current time. Most of Diaceutics PLC's value examination focuses on studying past and present price action to predict the probability of Diaceutics PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Diaceutics PLC's price. Additionally, you may evaluate how the addition of Diaceutics PLC to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |